Alan Collier Email & Phone

CEO @ Endonovo Therapeutics, Inc.

@ Sofpulse

Chief Executive Officer @ IP Resources International, Inc.

Senior Managing Director @ Mid-Market Securities, LLC

Managing Member @ C2 Capital

Vice President @ Corporate Capital Group, LLC

1984 - 1986 @ Arizona State University

- @ California State University - Northridge

Bioscience, Business Analysis, Business Integration, Business Strategy, Business Management, Contract Negotiation, Corporate Finance, Corporate Governance, Financial Analysis, Global Commercialization, Healthcare, Intellectual Property, Investment Banking, Joint Ventures, Licensing, Medical Devices, Mergers, New Business Development, Organizational Development, Product Development, Strategic Planning, Telecommunications, Underwriting, Web Development, Wireless, 3D, Emerging Markets, Alternative Investments, Growth Capital, M&A experience, Business Planning, Private Equity, Equities, Capital, Deal Sourcing, Debt Restructuring, Project Finance, IPO, Reverse Mergers, Venture Capital, Financial Structuring, Start-ups, Securities, Corporate Development, Restructuring, LBO, Valuation, Capital Raising, Private Placements, Finance, Start Ups

Alan Collier, based in California, United States, is currently a CEO at Endonovo Therapeutics, Inc.. Alan Collier brings experience from previous roles at Sofpulse, IP Resources International, Inc., Mid-Market Securities, LLC, C2 Capital, Corporate Capital Group, LLC. Alan Collier holds various educational qualifications (1984 - 1986) from Arizona State University. With a robust skill set that includes Bioscience, Business Analysis, Business Integration, Business Strategy, Business Management, Alan Collier demonstrates proficiency in a wide range of areas.